HealthLX & Timmaron Group Partner to Help Payers Meet Cures Act Mandates for Interoperability


HealthLX announced today that it has formed a systems integrator partnership with Timmaron Group to help healthcare payers comply with the CMS Interoperability and Patient Access final rule. By July 1, 2021, most health plans in the United States must enable member access to their records through an API or risk enforcement actions.

“HealthLX and Timmaron Group have been pursuing the same objective – radically advancing healthcare in the U.S. one organization at a time – for several years now,” said Will Tesch, CEO of HealthLX. “Now that the CMS Patient Access final rule is in the books and deadlines are upon us, it’s the right time to formalize our partnership. With HealthLX’s FHIR Enterprise solution and Timmaron’s experience and relationships with payers across the industry, we can help payers make genuine interoperability happen and do so quickly.”

“People are making life-change decisions off the work we are doing,” said Barbara Stinnett, CEO of Timmaron Group. “Having a partner like HealthLX who understands not just how to connect the data but also the strategy behind it is invaluable. Together we’re positioned to create incredible value as well as compliance capability for healthcare organizations and the members they serve.”

HealthLX is a recognized leader in solving clinical data integration challenges with its leading-edge technology. As a founding member of the Da Vinci Project, HealthLX is involved in writing the workflows to satisfy interoperability mandates. Timmaron Group works with healthcare organizations to use actionable data to achieve Triple Aim results, including stronger outcomes, cost benefits, and efficiencies in delivery of care.

“HealthLX and Timmaron Group have been speaking the same language for years,” said Tesch. “By working together, we’re creating a powerhouse solution that, with the CMS Patient Access mandates, has the potential to fundamentally improve healthcare for all stakeholders.”

About HealthLX

HealthLX™ (Healthcare Language Exchange) gives payers and providers an interoperability engine designed specifically for healthcare data exchange, including the CMS Interoperability and Patient Access Final Rule. The HealthLX platform supports FHIR natively, and also supports an array of older healthcare data standards (HL7 v2, EDI, CDA). HealthLX simplifies the effort and cost of new solution integration by creating modern API endpoints on legacy systems, all while providing highly configurable security and enhanced levels of transaction monitoring. As a founding member of Health Level Seven International’s (HL7) Da Vinci Project, HealthLX has been working with and supporting the development of use cases and the FHIR standard itself to comply with the Cures Act mandates. For more information, visit http://www.healthlx.com.

For media inquiries, please contact:

Jennifer Behnke

Director of Marketing, HealthLX

marketing@healthlx.com

About Timmaron Group

Timmaron Group is a global technologies, consulting, and managed services organization, and is ‘all about the data’, being an artificial technologies and healthcare company. Timmaron works with early-stage to Fortune 100 companies, developing their strategies through execution plans.

Timmaron Group is headquartered in Palo Alto, California. Its operating professionals bring a sensible and experienced view, provide innovative yet pragmatic solutions, and work with clients as a team member from strategy formation through execution to results. Learn more at http://www.timmarongroup.com.

For media inquiries, please contact:

Barbara Stinnett

CEO, Timmaron Group

+1 (612)991-0459

Share article on social media or email:

Leave a Reply